Role of B-1a cells in autoimmunity

被引:214
作者
Duan, Byian [1 ]
Morel, Laurence [1 ]
机构
[1] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
关键词
B-1a cells; CD5; antibodies; autoimmunity; lupus;
D O I
10.1016/j.autrev.2005.10.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
B-1a cells are distinguished from conventional B cells (B2) by their developmental origin, their surface marker expression and their functions. They were originally identified as a B cell subset of fetal origin that expresses the pan-T cell surface glycoprotein, CD5. B-1a cells also differ from B2 by the expression levels of several surface markers, including IgM, IgD, CD43 and B220 [R. Berland, H.H. Wortis, Origins and functions of B-1 cells with notes on the role of CD5. Ann Rev Immunol, 20 (2002) 253-300. [1]]. The majority of B-1a cells are located in peritoneal and pleural cavities. Compared to B2 cells, B-1a are long-lived, non-circulating, with reduced BCR diversity and affinity [A.B. Kantor, C.E. Merrill, L.A. Herzenberg, J.L. Hillson, An unbiased analysis of V-H-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol, 158 (1997) 1175-1186. [2]]. B-1a cells are largely responsible for the production of circulating IgM referred to as natural antibodies. These low affinity antibodies are polyreactive and constitute as such a first line of defense against bacterial pathogens [M.C. Carroll, A.P. Prodcus, Linkages of innate and adaptive immunity. Curr Opin Immunol, 10 (1998) 36-40. [3]]. This polyreactivity also results into the recognition of autoantigens, which serves in the clearance of apoptosis products. The weak autoreactivity of the B-1a cells has been postulated to play a role in autoimmune pathogenesis. In addition, other characteristics, such as the production of high level of IL-10 [A. O'Garra, R. Chang, N. Go, R. Hastings, G. Haughton, M. Howard, et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol, 22 (1992) 711-717. [4]] and enhanced antigen presentation capacities [C. Mohan, L. Morel, P. Yang, E.K. Wakeland, Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis and Rheumatism, 41 (1998) 1652-1662. [5]], have implicated B-1 a cells in autoimmunity. This review will discuss the current understandings of their role in autoimmune diseases with focus on lupus. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 51 条
[1]
Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells [J].
Atencio, S ;
Amano, H ;
Izui, S ;
Kotzin, BL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (07) :4159-4166
[2]
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection [J].
Baumgarth, N ;
Herman, OC ;
Jager, GC ;
Brown, LE ;
Herzenberg, LA ;
Chen, JZ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :271-280
[3]
The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS) [J].
Beebe, AM ;
Cua, DJ ;
Malefyt, RD .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :403-412
[4]
Origins and functions of B-1 cells with notes on the role of CD5 [J].
Berland, R ;
Wortis, HH .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :253-300
[5]
CALIGARISCAPPIO F, 1989, BLOOD, V73, P1259
[6]
Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36
[7]
The central and multiple roles of B cells in lupus pathogenesis [J].
Chan, OTM ;
Madaio, MP ;
Shlomchik, MJ .
IMMUNOLOGICAL REVIEWS, 1999, 169 :107-121
[8]
A VH11Vκ9B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro [J].
Chumley, MJ ;
Dal Porto, JM ;
Kawaguchi, S ;
Cambier, JC ;
Nemazee, D ;
Hardy, RR .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4586-4593
[9]
B-1 cell development:: Evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation [J].
Clarke, SH ;
Arnold, LW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) :1325-1334
[10]
CONG YZ, 1991, INT IMMUNOL, V3, P467